LIVE

MMS

Maximus, Inc.

MMS

NYSE·Industrials·Specialty Business Services·Mkt cap $2.8B

$55.75

▲ +3.57%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$52.73 - $100.00

P/E

8.49

Fwd P/E

6.61

Beta

0.58

Div Yield

2.34%

Avg Vol

773.8K

Shares Out

54.5M

Mkt Cap

$2.8B

Price action

Price chart

Down 25.7% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

5 reasons

  • Long-term government contracts providing stable, recurring revenue streams
  • Deep expertise in complex healthcare and social services program administration
  • Established relationships with federal, state, and local government agencies
  • Multilingual, multichannel customer engagement capabilities at scale
  • Specialized knowledge in benefits eligibility, enrollment, and appeals processes
▼

Bear Case

1 risk

  • Low volatility (beta 0.6).

Growth

Stable outlook

Expansion of government health programs and increasing Medicaid enrollment

Value

Deep value opportunity - significant discount to Business Process Outsourcing peers

Momentum

Weak

-13.7% over 3m

Quality

Stable

Strong fundamentals

Dividend

Solid

2.34% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 6, 2026

“
Q2 26 RECAP

MAY 7, 2026

Reported EPS of $2.07 vs $1.98 consensus (+4.5% surprise). Revenue of $1.3B vs $1.3B expected (-0.6%).

EPS beat +4.5%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+4.5%

Next: May 6, 2026

Revenue trend · last 8Q

—

—

—

+6%

+1%

+3%

+0%

-4%

Q2 24

Q3 24

Q4 24

Q1 24

Q2 25

Q3 25

Q4 25

Q1 25

$1.3B

$1.3B

$1.3B

$1.4B

$1.4B

$1.3B

$1.3B

$1.3B

Margins · last 8Q

Gross

22.2%

Operating

10.2%

Profit

7.0%

View full earnings history →

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

View full analyst page →

vs Industry

How MMS stacks vs Specialty Business Services

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.